Literature DB >> 30299102

Electron Paramagnetic Resonance and Small-Angle X-ray Scattering Characterization of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Dibucaine Encapsulation.

Raquel M Barbosa1,2, Bruna R Casadei3, Evandro L Duarte4, Patrícia Severino5, Leandro R S Barbosa4, Nelson Duran6, Eneida de Paula1.   

Abstract

Dibucaine (DBC) is one of the most potent long-acting local anesthetics, but it also has significant toxic side effects and low water solubility. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have been proposed as drug-delivery systems to increase the bioavailability of local anesthetics. The purpose of the present study was to characterize SLNs and NLCs composed of cetyl palmitate or myristyl myristate, a mixture of capric and caprylic acids (for NLCs only) plus Pluronic F68 prepared for the encapsulation of DBC. We intended to provide a careful structural characterization of the nanoparticles to identify the relevant architectural parameters that lead to the desirable biological response. Initially, SLNs and NLCs were assessed in terms of their size distribution, morphology, surface charge, and drug loading. Spectroscopic techniques (infrared spectroscopy and electron paramagnetic resonance, EPR) plus small-angle X-ray scattering (SAXS) provided information on the interactions between nanoparticle components and their structural organization. The sizes of nanoparticles were in the 180 nm range with low polydispersity and negative zeta values (-25 to -46 mV). The partition coefficient of DBC between nanoparticles and water at pH 8.2 was very high (>104). EPR (with doxyl-stearate spin labels) data revealed the existence of lamellar arrangements inside the lipid nanoparticles, which was also confirmed by SAXS experiments. Moreover, the addition of DBC increased the molecular packing of both SLN and NLC lipids, indicative of DBC insertion between the lipids, in the milieu assessed by spin labels. Such structural information brings insights into understanding the molecular organization of these versatile drug-delivery systems which have already demonstrated their potential for therapeutic applications in pain control.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30299102     DOI: 10.1021/acs.langmuir.8b02559

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  4 in total

1.  Hybrid Lipid/Clay Carrier Systems Containing Annatto Oil for Topical Formulations.

Authors:  Raquel de Melo Barbosa; Aliana Monteiro Leite; Fátima García-Villén; Rita Sánchez-Espejo; Pilar Cerezo; César Viseras; Angela Faccendini; Giuseppina Sandri; Fernanda Nervo Raffin; Túlio Flávio Accioly de Lima E Moura
Journal:  Pharmaceutics       Date:  2022-05-17       Impact factor: 6.525

Review 2.  Challenges in the Physical Characterization of Lipid Nanoparticles.

Authors:  Supandeep Singh Hallan; Maddalena Sguizzato; Elisabetta Esposito; Rita Cortesi
Journal:  Pharmaceutics       Date:  2021-04-14       Impact factor: 6.321

3.  Solid Lipid Nanoparticles for Dibucaine Sustained Release.

Authors:  Raquel de M Barbosa; Ligia N M Ribeiro; Bruna R Casadei; Camila M G da Silva; Viviane A Queiróz; Nelson Duran; Daniele R de Araújo; Patrícia Severino; Eneida de Paula
Journal:  Pharmaceutics       Date:  2018-11-14       Impact factor: 6.321

4.  Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis.

Authors:  Jéssica Adriana Jesus; Ilza Maria Oliveira Sousa; Thays Nicolli Fragoso da Silva; Aurea Favero Ferreira; Márcia Dalastra Laurenti; Leila Antonangelo; Caroline Silvério Faria; Paulo Cardoso da Costa; Domingos de Carvalho Ferreira; Luiz Felipe Domingues Passero
Journal:  Pharmaceutics       Date:  2021-06-19       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.